Navigation Links
Cell Transplants Hold Promise for Heart Attack Survivors
Date:12/6/2007

Studies in mice suggest they might prevent cardiac arrest

THURSDAY, Dec. 6 (HealthDay News) -- Researchers say they're moving closer to using transplanted cells to protect heart attack survivors from suffering sudden cardiac arrest.

Working with mice, scientists strengthened the heart's electrical system to prevent it from going haywire. "We're showing that the electrical risk can be reversed," said study co-author Dr. Michael Kotlikoff, a professor in the department of biomedical sciences at Cornell University.

It's still unclear, however, how long it may take before the research could be tested in humans.

At stake is the health of people who survive heart attacks. They face a higher risk of another life-threatening event known as cardiac arrest, which occurs when the electrical system in the heart loses its ability to properly control heartbeat.

The heart "goes into an irregular rhythm, stops functioning and stops pumping blood at all," Kotlikoff said.

The higher risk may have something to do with disruption in cells around areas of the heart that were damaged during a heart attack, said Dr. Kenneth Chien, director of the Massachusetts General Hospital Cardiovascular Research Center in Boston. He was not involved in the research.

According to the new study, previous transplantation of cells into human heart-attack survivors has had mixed results. So, Kotlikoff and colleagues from Germany and the United States tried a new approach by transplanting genetically engineered embryonic heart cells into the hearts of mice after they had heart attacks.

According to Kotlikoff, the cells become mature heart cells and produce a molecule that helps electrical impulses move between cells.

The new findings, which are published in the Dec. 6 issue of Nature, have now outlined the "mechanism underlying the reversal" of the risk of irregular heartbeat after a heart attack, Kotlikoff said.

Cell transplantation "increases the electrical conduction within the damaged or dead section of (heart) tissue," he said.

According to Kotlikoff, the next steps are to figure out whether the cells could provide protection in people and for how long.

Potentially, the cells could be delivered to the heart -- perhaps through a tube -- and prevent heart-attack survivors from having to get pacemakers, Kotlikoff said.

Chien called the study findings "a step in the right direction," but said the method's blend of gene and cell-based therapy could be troublesome. Federal regulators "are very stringent about gene therapy, let alone gene and cell therapy (together)," he said.

More information

There's more on cardiac arrest and heart attack at the American Heart Association.



SOURCES: Michael Kotlikoff, V.M.D., Ph.D., Austin O. Hooey Dean, professor, Department of Biomedical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, N.Y.; Kenneth Chien, M.D., director, Massachusetts General Hospital Cardiovascular Research Center, Boston; Dec. 6, 2007, Nature


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. National Foundation for Transplants to Expand Program Providing Hotel Accommodations to Patient Families
2. New Heart Pump Helps Women Awaiting Transplants
3. Blood-incompatible infant heart transplants safe, may save more lives
4. Blood-Incompatible Heart Transplants Safe for Infants
5. Lung Transplants May Not Help Most Cystic Fibrosis Children
6. Alcohol may amplify chronic rejection in lung transplants
7. Bone marrow cell transplants help nerve regeneration
8. New study shows promise in reducing surgical risks associated with surgical bleeding
9. New Heart Pump Shows Promise in Trial
10. Blood-flow detector software show promise in preventing brain damage
11. New type of drug shows promise in attacking melanoma in an innovative way
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cell Transplants Hold Promise for Heart Attack Survivors
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, a provider ... that a new solution for Emergency Departments (ED) has been added to their ... Emergency Department examination rooms, and with a simplified pallet of information available to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... with distinction by the Undersea and Hyperbaric Medical Society (UHMS), the leading authority ... care and patient safety. Only a few hospitals and facilities have earned this ...
(Date:12/8/2016)... ... December 08, 2016 , ... Seavest ... Property owned by an affiliate of Seavest, has won a prestigious national healthcare ... Chester County ambulatory care center (ACC) was named “Best New Development, MOBs and ...
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , ... Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont ... and attorneys from the firm’s global Life Sciences & Medical Technology Group have been ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... the largest share of the market in 2016 and ... dominance can be attributed to a large number of ... (US hold the largest share in the patient temperature ... benefits such as reducing loss of blood during surgeries, ...
(Date:12/8/2016)... 8, 2016 Research and Markets has announced ... Trends - Adhesion Type, Application, Usability - Forecast to 2025" ... , ... Market is poised to grow at a CAGR of around 3.2% ... market is witnessing include advancements in extracellular microelectrode arrays and intracellular ...
(Date:12/8/2016)... Quebec , Dec. 8, 2016  Valeant ... and TSX: VRX) ("Valeant") today announced positive results ... clinical study to assess the safety and efficacy ... the treatment of plaque psoriasis. ... subjects with moderate to severe psoriasis, IDP-118 showed ...
Breaking Medicine Technology: